Celerus Diagnostics will introduce a totally automated immunohistochemistry (IHC) staining system, the much-anticipated Wave RPD, at the United States and Canadian Association of Pathologists (USCAP) annual meeting being held in Washington DC, March 22 to 24.
The new system is the first of its kind, capable of delivering totally automated IHC results in one hour.
"We’re extremely proud to present the Wave RPD, our second generation Rapid IHC® system," said CEO Dave Gross. "The Wave RPD System is unparalleled in the industry and this annual meeting of leading US and Canadian pathologists is the ideal venue for its introduction."
On-board heating technology and sophisticated thermal control software have been added to the Wave RPD System, allowing for rapid deparaffinization and antigen retrieval. These steps, along with the patented Wave motion technology, deliver Rapid IHC results in one hour. This significantly improved turnaround time is one third of other IHC instruments taking up to three or more hours.
"Pathologists will have the ability to see IHC results that can aid in a differential diagnosis faster than ever before," said Jason Lusk, VP of Business Development. "For a patient waiting on laboratory tests, a possible cancer diagnosis and subsequent treatment options, this reduced turnaround time is significant. The Wave RPD System will deliver the fastest standardized, high-quality IHC results available."
The new capabilities of the Wave RPD System will drive future growth at Celerus beyond IHC and into rapid molecular assays. Feasibility has now been demonstrated for same-day fluorescent in situ hybridization (FISH) and same-day chromogenic in situ hybridization (CISH) of common DNA targets such as Her2/neu.
Source: Celerus Diagnostics
